Diabetes Therapies & Diagnostics: Global Markets

Publication Date	January 2008
Publisher	BCC Research
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	BCC00216

Price

£3,320.00
approximately: $4,851 | €3,639

PDF

PRINT £3,320 ($4,851 | €3,639)

Order above formats by FAX

Summary

Introduction

Bcc's Goal In Conducting This Study Was To Determine The Current Status Of The Global Diabetes Market And Assess Its Growth Potential Over A 5-Year Period From 2008 To 2013. Of Particular Interest Were The Market Segment Position Of The Diagnostics And Therapeutics In Relation To Management Of Diabetic Condition And Diabetic Complications For The Fast Growing Global Diabetic Community, If The Prediction Of Global Epidemic Prevalence Of Type Ii Diabetes Population Is Fulfilled.

In Addition, Bcc Was Interested In The Market Potential For New Insulin Infusion Pumps, Non-Invasive Insulin Delivery Methods, And The New Class Of Incretin Mimetics Therapeutics For Diabetes Treatment As Well As Technology Innovation For Management Of Diabetes And Diabetic Complications.

The Key Objective Was To Present A Comprehensive Analysis Of The Current Diabetes Market And Its Future Direction To Meet The Unmet Demands Of Diabetic Consumers.

Scope Of Study

This Report Contains:

Descriptions Of Diabetes Therapeutics Including Drugs For Diabetes And Diabetes Complications, Diabetes Diagnostics Including Blood Glucose Testing Devices And Supplies, And All Other Interventions
The Current Global Market Status For Diabetes Therapeutics And Diagnostics, With Trends And Forecasts For Growth Over The Next 5 Years
Technological Issues Including The Latest Trends And A Thorough Patent Analysis
Discussion Of Predictions Of A Type Ii Diabetes Global Epidemic
Company Profiles.

Information Sources

Bcc Surveyed Approximately 70 Companies To Obtain Data For This Study. Included Were Manufacturers Of Glucose Monitoring Devices, Insulin Lancing Devices, Insulin Products, Insulin-Independent Antidiabetic Products, Products For Treatment Of Diabetic Complications, All In Fda Approved Brand-Name Products Or Fda Approved Generic Products, And Potential Drug Candidates Moving Up The Ladder In Clinical Trials From Phase I To Phase Iv. Bcc Also Spoke With Government Agency Regulators, Industry Personnel, And Medical Science Personnel. In Addition, Data Was Compiled From Current Financial, Legal, Trade Information, And Government Sources.

Analyst Credentials

Ann Zhai Was Trained In Oncology And Is A Registered Patent Agent With The United States Patent And Trademark Office. She Has Broad Experience In Business, Capital Markets, Government Regulation, And Intellectual Property Law In The Pharmaceutical, Medical Device, Healthcare Service, And Consumer Products Industries.

Content

Dawn Petershlc029b
Mar-08i
Introduction
Study Goals And Objectives
Reasons For Doing This Study
Intended Audience
Scope Of Report
Information Sources
Analyst Credentials
Related Reports
Bcc Online Services
Disclaimer
Summary
Summary Table Global Diabetes Market Forecast By Segment, Through 2013 ($ Billions)
Summary Figure Global Diabetes Market Forecast By Segment, 2006-2013 ($ Billions)
Overview
Overview
Table Prevalence Of Type And Diabetes: Top Six Countries With High Growth Projections, Through 2013 (Millions)
Table Prevalence Of Type Diabetes: Top Six Countries With Projections, Through 2013 (Millions)
Table Definitions Of The Four Types Of Diabetes
Table Summary Of Diabetes Products And Applications
Diabetes Disease
Causation, Risk Factors, And Complications
Table Causal Or Risk Factors By Diabetes Type
Table Complications By Type Of Diabetes
Diabetes Management
Diabetes Management
Diabetes Management
Diabetes Product Segments
Continuous Glucose Monitoring Systems (Cgms)
Continuous Glucose Monitoring
Table Fda Approved Continuous Glucose Monitoring Systems By Manufacturer
Insulin Infusion Pumps
Table Fda Approved Insulin Infusion Pumps By Manufacturer
Table Projected Market Leader Sales Of Continuous Glucose Monitoring Systems And Insulin Infusion Pumps, Through 2013 ($ Millions)
Figure Projected Market Leader Sales Of Continuous Glucose Monitoring Systems And Insulin Infusion Pumps, 2006-2013 ($ Millions)
Insulin-Dependent Drugs
Table Technological Evolution Of Insulin Delivery Methods
Table Fda Approved Insulin-Dependent Products
By Market Leader
Insulin-Dependent Drugs
Table Insulin-Dependent Drug Sales Forecast By Manufacturer, Through 2013 ($ Millions)
Figure Insulin-Dependent Drug Sales Forecast
By Manufacturer, 2006-2013 ($ Millions)
Insulin-Independent Drugs
Table The Seven Classes Of Type Diabetes Drugs
Sulfonylureas
Table Fda Approved Brand-Name Sulfonylurea
Drugs By Drugmaker
Biguanides
Table Fda Approved Brand-Name Biguanide Drugs
Alpha-Glucosidase Inhibitors
Table Fda Approved Brand-Name Alpha-Glucosidase Inhibitor Drugs
Meglitinides
Table Fda Approved Brand-Name Meglitinide Drugs
Thiazolidinediones (Tzd)
Table Fda Approved Brand-Name Thiazolidinediones Drugs
Incretin Mimetics
Table Fda Approved Brand-Name Incretin Mimetics Drugs
Dipeptidyl Peptidase (Dpp-)
Table Fda Approved Brand-Name Dpp- Drugs
Table Top Selling Brand-Name Insulin-Independent Drug Forecast, Through 2013 ($ Millions)
Figure Top Selling Brand-Name Insulin-Independent Drug Forecast, 2006-2013 ($ Millions)
Surgical Treatment Of Diabetes
Table The Market For New Classes Of Diabetes Treatments
Diabetic Complications Market
Retinopathy (Eye Disease)
Neuropathy (Nerve Disease)
Nephropathy (Kidney Disease)
Arteriosclerosis (Cardiovascular Disease)
Other Complications
Prescription Drugs For Diabetes Complications
Cholesterol Drugs
Torcetrapib (Pfizer)
Hypertension Drugs
Exforge (Novartis)
Tekturna (Novartis)
Coronary Intervention
Effient (Eli Lilly/Daiichi Sankyo)
Table Drugs Used To Treat Common Diabetic Complications, By Manufacturer
Table Forecast Of Top Selling Drugs Used In The Treatment Of Common Diabetic Complications By Manufacturer, Through 2013 ($ Millions)
Figure Forecast Of Top Selling Drugs Used In The Treatment Of Common Diabetic Complications By Manufacturer, 20062013 ($ Millions)
Generic Antidiabetic Drug Market
Generic Antidiabetic Drug Market
Table Fda Approved Generic Sulfonylureas By Manufacturer
Table Fda Approved Generic Biguanides By Manufacturer
Table Fda Approved Generic Meglitinides By Manufacturer
Table Fda Approved Generic Thiazolidinediones,
By Manufacturer
Table Top Selling Generic Antidiabetic Drug Forecast, Through 2013 ($ Millions)
Diabetes Drugs In Development
Clinical Trials Phases Iiv
Phase Clinical Trials On Diabetes Drugs
Table Diabetes Drugs In Phase Clinical Trials
Phase Clinical Trials On Diabetes Drugs
Table Diabetes Drugs In Phase Clinical Trials
Phase Iii Clinical Trials On Diabetes Drugs
Table Diabetes Drugs In Phase Iii Clinical Trials
Phase Iv Clinical Trials On Diabetes Drugs
Table Diabetes Drugs In Phase Iv Clinical Trials
Completed Clinical Trials On Type Diabetes Drugs
Table Completed Clinical Trials On Type Diabetes Drugs
Completed Clinical Trials On Type Diabetes Drugs
Table Completed Clinical Trials On Type Diabetes Drugs
Completed Clinical Trials On Drugs Used To Treat Both Types Of Diabetes
Table Completed Clinical Trials On Drugs Used To Treat Both Type And Type Diabetes
Phase Clinical Trials On Treatments For Diabetes Complications
Table Phase Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Phase Clinical Trials On Treatments For Diabetes Complications
Table Phase Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Phase Iii Clinical Trials On Treatments For Diabetes Complications
Table Phase Iii Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Phase Iv Clinical Trials On Treatments For Diabetes Complications
Table Phase Iv Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Completed Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Table Completed Clinical Trials On Drugs Used To Treat Common Diabetic Complications
Incretin Mimetics
Pramlintide
Exenatide
Liraglutide (Phase Iii)
Dpp- Inhibitors
Vildagliptin
Sitagliptin
Glitazars (Dual-Ppar Agonists)
Muraglitazar
Patent Analysis Of Diagnostic And Therapeutic Diabetes Treatments
Table Worldwide Shares Of Patents And Published Patent Applications On Type And Type Diabetes Treatments By Selected Country, //200111//2007 (Number)
U.S. And European Patents On Type Diabetes Treatments
Table U.S. And European Shares Of Patents On Type Diabetes Treatments By Patent Holder, //199111//2007 (Number)
U.S. And European Patents On Type Diabetes Treatments
Table U.S. And European Shares Of Patents On Type Diabetes Treatments By Patent Holder, //1991 To //2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Incretin Mimetics And Dpp- Inhibitors By Patent Holder, //200111//2007 (Number)
Table U.S. And European Shares Of Patents On Incretin Mimetics And Dpp- Inhibitors By Patent Holder, //199111//2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Sitagliptin By Patent Holder, //200111//2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Vildagliptin By Patent Holder, //200111//2007 (Number)
Table U.S. Patent Shares Of Vildagliptin By Patent Holder, //199111//2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Saxagliptin By Patent Holder, //200111//2007 (Number)
Table U.S. Patent Shares Of Liraglutide By Patent Holder,
//199111//2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Tesaglitazar By Patent Holder, //200111//2007 (Number)
Table Worldwide Shares Of Patents And Patent Applications On Muraglitazar By Patent Holder, //200111//2007 (Number)
U.S. And European Patents On Insulin Delivery Other Than Subcutaneous Methods
Table U.S. And European Shares Of Patents On Insulin Delivery Other Than Subcutaneous Methods, //199111//2007 (Number)
U.S. And European Patents On Insulin Infusion Pumps
Table U.S. And European Shares Of Patents On Insulin Infusion Pumps By Patent Holder, //199111//2007 (Number)
U.S. And European Patents On Continuous Glucose Monitoring Systems
Table U.S. And European Shares Of Patents On Continuous Glucose Monitoring Systems By Patent Holder,
//199111//2007 (Number)
Table U.S. And European Shares Of Patents On Blood Glucose Meters By Patent Holder, //199111//2007 (Number)
Insulin Inhaler Market
Drugmakers Developing Inhalable Insulin
Pfizer
Abbott Laboratories And Kos Pharmaceuticals
Eli Lilly & Co. And Alkermes
Mannkind Corp.
Novo Nordisk And Aradigm
Baxter International
Nastech Pharmaceutical Co.
Generex Biotechnology
Table Inhaled Insulin Products Under Development By Company
Insulin Infusion Pump Market
Insulin Infusion Pump Market
Insulin Infusion Pump Market
Insulin Infusion Pump Market
Insulin Infusion Pump Market
Insulin Dispensing Patch Market
Insulin Dispensing Patch Market
Table Insulin Dispensing Patches By Manufacturer
Company Profiles
Abbott Laboratories, Inc.
Abbott Diabetes Care, Inc.
Actavis
Actavis U.S.
Alizyme, Plc
Alkermes Inc.
Alkermes Inc.
Amylin Pharmaceutcials, Inc.
Aradigm Corp.
Astella Pharmaceuticals
Astrazeneca, Plc
Astrazeneca U.S.
Astrazeneca U.S. (Continued)
Barr Pharmaceuticals, Inc.
Barr Pharmaceuticals, Inc.
Bayer Schering Pharma Ag
Bayer Healthcare Pharmaceuticals U.S.
Bayer Global Healthcare Diabetes Care
Bayer Global Healthcare Diabetes Care (Continued)
Bayer Global Healthcare Diabetes Care (Continued)
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co.
Caraco Pharma Labs, Ltd.
Daiichi-Sankyo, Ltd.
Daiichi-Sankyo, Inc.
Daiichi-Sankyo, Inc. (Continued)
Debiotech
Depomed, Inc.
Depomed, Inc.
Dexcom
Dr. Reddys Laboratories, Ltd.
Dr. Reddys Laboratories, Ltd.
Eli Lilly & Co.
Eli Lilly & Co.
Eli Lilly & Co.
Eli Lilly & Co.
Glaxosmithkline, Plc
Glaxosmithkline
Insulet Corp.
Johnson & Johnson Co.
Lifescan, Inc.
Keryx Biopharmaceuticals Inc.
Mannkind Corp.
Mannkind Corp.
Medtronic Inc.
Medtronic Diabetes
Medtronic Diabetes (Continued)
Merck & Co., Inc.
Merck & Co., Inc.
Mylan, Inc.
Novartis Ag
Novartis U.S.
Novartis U.S. (Continued)
Novo Nordisk A/S
Novo Nordisk U.S.
Novo Nordisk U.S. (Continued)
Par Pharmaceutical Companies, Inc.
Pfizer, Inc.
Ranbaxy Laboratories, Inc.
Ranbaxy U.S.
Roche Diagnostics Corp.
Sandoz (Novartis Generic Division)
Sandoz U.S.
Sanofi-Aventis A.G.
Sanofi-Aventis U.S., Llc
Sanofi-Aventis U.S., Llc (Continued)
Santhera Pharmaceuticals
Smiths Medical
Smiths Medical Asd, Inc.
Takeda Pharmaceutical Co., Ltd.
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals Usa
Watson Laboratories, Inc.
Wyeth
Wyeth